Defendant Name: Fresenius Medical Care AG & Co. KGaA 

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 35802910

Initial Case Details

Legal Case Name In the Matter of Fresenius Medical Care AG & Co. KGaA
First Document Date 29-Mar-2019
Initial Filing Format Administrative Action
File Number 3-19126
Allegation Type Foreign Corrupt Practices Act
AAER 4033

Violations Alleged

Exchange Act
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)
Sec 30A


First Resolution Date 29-Mar-2019
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

34-85468 29-Mar-2019 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On March 29, 2019, the SEC issued an order against Fresenius Medical Care AG & Co. KGaA stating: "This matter concerns violations of the anti-bribery, books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act of 1977 (the "FCPA") [...] by FMC, a world-wide provider of products and services for individuals with chronic kidney failure headquartered in Bad Homburg, Germany."
2019-48 29-Mar-2019 Press Release--Administrative Proceeding
SEC Charges Medical Device Company With FCPA Violations
The SEC stated that: "Fresenius Medical Care AG & Co KGaA (FMC) has agreed to pay more than $231 million to resolve parallel SEC and U.S. Department of Justice investigations related to its violations of the Foreign Corrupt Practices Act (FCPA) across multiple countries for nearly a decade."